HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-OCT-17 6B8U TITLE CRYSTALS STRUCTURE OF B-RAF KINASE DOMAIN IN COMPLEX WITH AN TITLE 2 IMIDAZOPYRIDINYL BENZAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 445-723; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 6 HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF21; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBLUEBAC4.5 KEYWDS PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL ONCOGENE KEYWDS 2 HOMOLOG B1, ONCOPROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.A.APPLETON,J.MURRAY,C.M.SHAFER REVDAT 3 04-OCT-23 6B8U 1 REMARK REVDAT 2 29-NOV-17 6B8U 1 JRNL REVDAT 1 22-NOV-17 6B8U 0 JRNL AUTH A.SMITH,Z.J.NI,D.POON,Z.HUANG,Z.CHEN,Q.ZHANG,L.TANDESKE, JRNL AUTH 2 H.MERRITT,K.SHOEMAKER,J.CHAN,S.KAUFMAN,K.HUH,J.MURRAY, JRNL AUTH 3 B.A.APPLETON,S.W.COWAN-JACOB,C.SCHEUFLER,T.KANAZAWA, JRNL AUTH 4 J.M.JANSEN,D.STUART,C.M.SHAFER JRNL TITL IMIDAZO[1,2-A]PYRIDIN-6-YL-BENZAMIDE ANALOGS AS POTENT RAF JRNL TITL 2 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 5221 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 29107542 JRNL DOI 10.1016/J.BMCL.2017.10.047 REMARK 2 REMARK 2 RESOLUTION. 2.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 21086 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1085 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.68 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.35 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2669 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2036 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2517 REMARK 3 BIN R VALUE (WORKING SET) : 0.1991 REMARK 3 BIN FREE R VALUE : 0.2787 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3944 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.75730 REMARK 3 B22 (A**2) : -2.75730 REMARK 3 B33 (A**2) : 5.51470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.296 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.490 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.259 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.452 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.258 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4100 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5546 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1419 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 652 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4100 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 528 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4643 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.05 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.68 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -20.8599 5.7337 1.2720 REMARK 3 T TENSOR REMARK 3 T11: -0.0715 T22: -0.0318 REMARK 3 T33: -0.0910 T12: -0.0375 REMARK 3 T13: -0.0036 T23: 0.0467 REMARK 3 L TENSOR REMARK 3 L11: 1.6390 L22: 0.7264 REMARK 3 L33: 1.3183 L12: -0.5493 REMARK 3 L13: 0.8139 L23: -0.4640 REMARK 3 S TENSOR REMARK 3 S11: 0.0679 S12: -0.0765 S13: -0.1017 REMARK 3 S21: 0.0465 S22: -0.0330 S23: -0.1037 REMARK 3 S31: 0.0784 S32: 0.0727 S33: -0.0349 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -41.4854 26.9649 -14.4915 REMARK 3 T TENSOR REMARK 3 T11: -0.1111 T22: -0.0763 REMARK 3 T33: -0.0672 T12: 0.0162 REMARK 3 T13: 0.0134 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 1.0266 L22: 1.8802 REMARK 3 L33: 1.9708 L12: -0.4530 REMARK 3 L13: 0.5228 L23: -1.1911 REMARK 3 S TENSOR REMARK 3 S11: 0.0722 S12: 0.0341 S13: 0.2234 REMARK 3 S21: 0.0793 S22: -0.0375 S23: 0.0820 REMARK 3 S31: -0.1967 S32: -0.0623 S33: -0.0347 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6B8U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000226171. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11589 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21143 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.680 REMARK 200 RESOLUTION RANGE LOW (A) : 46.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.15200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : 0.76800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2FB8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG8000, 0.1 M SODIUM CITRATE PH REMARK 280 4.7, AND 0.2 M SODIUM CHLORIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.35150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.75100 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.75100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.17575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.75100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.75100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 123.52725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.75100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.75100 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.17575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.75100 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.75100 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 123.52725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 82.35150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 443 REMARK 465 SER A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 LYS A 630 REMARK 465 LEU A 721 REMARK 465 PRO A 722 REMARK 465 LYS A 723 REMARK 465 GLY B 443 REMARK 465 SER B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 LEU B 485 REMARK 465 ASN B 486 REMARK 465 VAL B 487 REMARK 465 THR B 488 REMARK 465 LEU B 597 REMARK 465 ALA B 598 REMARK 465 THR B 599 REMARK 465 VAL B 600 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 GLY B 615 REMARK 465 GLN B 628 REMARK 465 ASP B 629 REMARK 465 LYS B 630 REMARK 465 LEU B 721 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 468 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 485 CG CD1 CD2 REMARK 470 ASN A 486 CG OD1 ND2 REMARK 470 VAL A 487 CG1 CG2 REMARK 470 THR A 488 OG1 CG2 REMARK 470 GLN A 493 CG CD OE1 NE2 REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 MET A 627 CG SD CE REMARK 470 ASN A 631 CG OD1 ND2 REMARK 470 LYS A 700 CG CD CE NZ REMARK 470 ASP B 449 CG OD1 OD2 REMARK 470 GLN B 461 CG CD OE1 NE2 REMARK 470 GLN B 493 CG CD OE1 NE2 REMARK 470 LYS B 522 CG CD CE NZ REMARK 470 LYS B 547 CG CD CE NZ REMARK 470 MET B 627 CG SD CE REMARK 470 ARG B 691 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 702 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 476 89.56 -162.91 REMARK 500 ARG A 575 -7.03 79.37 REMARK 500 ASP A 576 43.24 -151.54 REMARK 500 LEU A 588 -45.61 -138.01 REMARK 500 ARG A 626 -102.82 -66.60 REMARK 500 ARG A 682 148.79 -39.71 REMARK 500 ASP B 449 60.98 67.83 REMARK 500 TRP B 476 91.56 -163.24 REMARK 500 ARG B 575 -6.72 79.20 REMARK 500 ASP B 576 42.66 -152.44 REMARK 500 LEU B 588 -45.76 -137.58 REMARK 500 ARG B 682 148.13 -39.69 REMARK 500 ARG B 719 57.37 -90.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8EN A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8EN B 801 DBREF 6B8U A 445 723 UNP P15056 BRAF_HUMAN 445 723 DBREF 6B8U B 445 723 UNP P15056 BRAF_HUMAN 445 723 SEQADV 6B8U GLY A 443 UNP P15056 EXPRESSION TAG SEQADV 6B8U SER A 444 UNP P15056 EXPRESSION TAG SEQADV 6B8U GLY B 443 UNP P15056 EXPRESSION TAG SEQADV 6B8U SER B 444 UNP P15056 EXPRESSION TAG SEQRES 1 A 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 281 LEU LEU ALA ARG SER LEU PRO LYS SEQRES 1 B 281 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 281 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 281 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 281 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 281 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 281 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 281 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 281 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 281 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 281 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 281 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 281 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 281 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 281 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 281 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 281 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 281 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 281 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 281 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 281 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 281 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 281 LEU LEU ALA ARG SER LEU PRO LYS HET 8EN A 801 33 HET 8EN B 801 33 HETNAM 8EN ~{N}-[3-(2-ACETAMIDOIMIDAZO[1,2-A]PYRIDIN-6-YL)-4- HETNAM 2 8EN METHYL-PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE FORMUL 3 8EN 2(C24 H19 F3 N4 O2) FORMUL 5 HOH *111(H2 O) HELIX 1 AA1 THR A 491 ARG A 506 1 16 HELIX 2 AA2 SER A 536 ILE A 543 1 8 HELIX 3 AA3 GLU A 549 LYS A 570 1 22 HELIX 4 AA4 GLU A 586 LEU A 588 5 3 HELIX 5 AA5 SER A 616 MET A 620 5 5 HELIX 6 AA6 ALA A 621 ARG A 626 1 6 HELIX 7 AA7 SER A 634 GLY A 652 1 19 HELIX 8 AA8 ASN A 661 ARG A 671 1 11 HELIX 9 AA9 ASP A 677 VAL A 681 5 5 HELIX 10 AB1 PRO A 686 LEU A 697 1 12 HELIX 11 AB2 LYS A 700 ARG A 704 5 5 HELIX 12 AB3 LEU A 706 ARG A 719 1 14 HELIX 13 AB4 THR B 491 ARG B 506 1 16 HELIX 14 AB5 SER B 536 ILE B 543 1 8 HELIX 15 AB6 GLU B 549 LYS B 570 1 22 HELIX 16 AB7 GLU B 586 LEU B 588 5 3 HELIX 17 AB8 SER B 616 MET B 620 5 5 HELIX 18 AB9 ALA B 621 ARG B 626 1 6 HELIX 19 AC1 SER B 634 GLY B 652 1 19 HELIX 20 AC2 ASN B 661 ARG B 671 1 11 HELIX 21 AC3 ASP B 677 VAL B 681 5 5 HELIX 22 AC4 PRO B 686 LEU B 697 1 12 HELIX 23 AC5 LYS B 700 ARG B 704 5 5 HELIX 24 AC6 LEU B 706 ARG B 719 1 14 SHEET 1 AA1 5 THR A 458 SER A 465 0 SHEET 2 AA1 5 THR A 470 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 AA1 5 ASP A 479 MET A 484 -1 O MET A 484 N THR A 470 SHEET 4 AA1 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 AA2 2 ILE A 582 HIS A 585 0 SHEET 2 AA2 2 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 AA3 5 THR B 458 SER B 465 0 SHEET 2 AA3 5 THR B 470 LYS B 475 -1 O VAL B 471 N ILE B 463 SHEET 3 AA3 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 AA3 5 ALA B 526 GLN B 530 -1 O ILE B 527 N LYS B 483 SHEET 5 AA3 5 PHE B 516 SER B 520 -1 N MET B 517 O VAL B 528 SHEET 1 AA4 2 ILE B 582 HIS B 585 0 SHEET 2 AA4 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 LYS A 522 PRO A 523 0 1.34 CISPEP 2 LYS B 522 PRO B 523 0 3.24 SITE 1 AC1 15 ALA A 481 LYS A 483 GLU A 501 LEU A 505 SITE 2 AC1 15 LEU A 514 ILE A 527 THR A 529 TRP A 531 SITE 3 AC1 15 CYS A 532 ILE A 572 HIS A 574 GLY A 593 SITE 4 AC1 15 ASP A 594 PHE A 595 HOH B 910 SITE 1 AC2 18 ILE B 463 ALA B 481 LYS B 483 GLU B 501 SITE 2 AC2 18 LEU B 505 LEU B 514 ILE B 527 THR B 529 SITE 3 AC2 18 TRP B 531 CYS B 532 LEU B 567 ILE B 572 SITE 4 AC2 18 HIS B 574 GLY B 593 ASP B 594 PHE B 595 SITE 5 AC2 18 HOH B 911 HOH B 930 CRYST1 93.502 93.502 164.703 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010695 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010695 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006072 0.00000